IMRX Next Earnings Date Notes

— Immuneering Corporation (IMRX) is a clinical-stage biotechnology company focused on developing novel treatments for cancer, with a particular emphasis on targeting the MAPK pathway—one of the most frequently mutated pathways in cancer. Their leading drug candidate, IMM-1-104, is in clinical trials for patients with advanced solid tumors harboring RAS mutations, and the pipeline also includes preclinical compounds addressing additional oncology targets. When preparing for the next earnings call, investors should pay close attention to updates on clinical trial progression, especially safety & efficacy data from phase 1/2 studies of IMM-1-104, as these results are critical for regulatory advancement & partnership potential. Cash runway is another essential metric, as it reflects the company’s ability to fund operations until the next value inflection point; thus, monitoring cash & cash equivalents, R&D spend, and projected quarters of cash is paramount. Additionally, look for management commentary on partnership discussions & upcoming catalysts, as well as any changes to guidance regarding trial timelines or regulatory milestones—all of which will help you assess the likelihood of long-term success and value creation at Immuneering. The next projected earnings date for IMRX is 5/4/2026 after close (stay tuned for a confirmed earnings date once announced).

IMRX Next Earnings Date FAQ

On this page we presented the IMRX Next Earnings Date information for Immuneering along with recent past earnings dates. For Q4 of 2025, IMRX reported earnings of -0.180/share, with the earnings report taking place on 3/6/2026. For Q3 of 2025, IMRX reported earnings of -0.380/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, IMRX reported earnings of -0.400/share, with the earnings report taking place on 8/13/2025. For Q1 of 2025, IMRX reported earnings of -0.420/share, with the earnings report taking place on 5/5/2025. For Q4 of 2024, IMRX reported earnings of -0.580/share, with the earnings report taking place on 3/20/2025. Based on these past earnings dates, the projected next earnings date for IMRX is 5/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Immuneering. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Immuneering shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Immuneering next earnings dates as well as any other stock out there in our coverage universe, to see when the next IMRX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up IMRX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the IMRX next earnings date.